Can a patient take topiramate (Topamax) daily and rimegepant (Nurtec ODT) every other day for migraine prevention?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, you can take topiramate (Topamax) daily and rimegepant (Nurtec ODT) every other day together for migraine management.

This combination is explicitly supported by FDA labeling and clinical practice, as rimegepant is approved for preventive treatment at 75 mg every other day and can be used alongside other migraine preventive medications like topiramate. 1

Key Points About This Combination

FDA-Approved Dosing

  • Rimegepant (Nurtec ODT): 75 mg every other day for migraine prevention 1
  • Topiramate: Typically 50-100 mg daily for migraine prevention 2
  • The FDA label for rimegepant does not list topiramate as a contraindication or require dose adjustments when used together 1

Clinical Rationale

This combination makes clinical sense because:

  • Different mechanisms of action: Topiramate works through multiple pathways (sodium/calcium channel blockade, GABA enhancement, glutamate inhibition) 3, while rimegepant blocks CGRP receptors 4
  • Complementary effects: Many patients in rimegepant clinical trials were using concomitant preventive medications, demonstrating safety of combination use 5
  • Topiramate may be particularly beneficial if you also have comorbid conditions it treats (obesity, seizures) 6

Important Drug Interaction Considerations

What You Need to Avoid with Rimegepant

Do NOT take rimegepant within 48 hours if you're using: 1

  • Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, clarithromycin)
  • Moderate CYP3A4 inhibitors (e.g., erythromycin, fluconazole, verapamil)
  • Potent P-glycoprotein inhibitors (e.g., cyclosporine, quinidine)

Topiramate is NOT a CYP3A4 inhibitor or P-gp inhibitor, so it does not interfere with rimegepant metabolism 3

Topiramate-Specific Monitoring

When taking topiramate, you should be monitored for:

  • Metabolic acidosis and kidney stones: Check serum bicarbonate and renal function twice annually 7, 2
  • Cognitive effects: Start low (25 mg daily) and titrate slowly by 25 mg weekly to minimize cognitive side effects 2, 3
  • Adequate hydration: Essential to prevent kidney stones 8
  • Contraception if female: Topiramate is teratogenic (Pregnancy Category D) and absolutely contraindicated in pregnancy 2, 9

Practical Implementation

Starting This Combination

  1. If already on topiramate: Simply add rimegepant 75 mg every other day 1
  2. If starting both: Begin topiramate first at 25 mg daily, titrate slowly over 4-8 weeks to target dose (typically 100 mg daily), then add rimegepant 2
  3. Take rimegepant on a consistent every-other-day schedule (e.g., Monday-Wednesday-Friday-Sunday pattern) 1

Expected Benefits

  • Rimegepant reduces migraine days by approximately 4 days per month compared to baseline 5
  • Topiramate reduces migraine frequency by 50% or more in about 46% of patients 10
  • Combined therapy may provide additive benefits through different mechanisms 11

Common Pitfalls to Avoid

Medication Overuse Headache Risk

  • Limit rimegepant to every other day for prevention (not daily) 1
  • If using rimegepant for acute treatment as well, do not exceed 18 doses in 30 days 1
  • Be aware that using acute medications (triptans, NSAIDs) ≥10-15 days per month can cause medication overuse headache 12, 13

Topiramate Side Effects

The most problematic side effects are:

  • Cognitive impairment (word-finding difficulty, mental slowing): Minimize by slow titration 3, 8
  • Paresthesias (tingling): Common but usually not treatment-limiting 8
  • Weight loss: May be beneficial if overweight, but monitor 6

Special Populations

Women of childbearing potential:

  • Topiramate is absolutely contraindicated in pregnancy due to increased risk of oral clefts 2, 9
  • Requires effective contraception and is now considered unsuitable as first-line treatment in this population 9
  • Rimegepant pregnancy data are limited; enrollment in pregnancy registry recommended 1

When to Reassess

Evaluate treatment response after 2-3 months 2, 13:

  • Track migraine frequency using a headache diary
  • If inadequate response (<50% reduction in migraine days), consider adjusting topiramate dose up to 100-150 mg daily 2
  • If side effects are intolerable, consider switching to alternative preventives (beta-blockers, anti-CGRP monoclonal antibodies) 13

This combination represents a rational, evidence-based approach using both a traditional preventive (topiramate) and a newer CGRP-targeted therapy (rimegepant) with complementary mechanisms of action.

References

Guideline

diagnosis and management of migraine in ten steps.

Nature Reviews Neurology, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.